Mubarak Alfaresi

1.5k total citations
39 papers, 854 citations indexed

About

Mubarak Alfaresi is a scholar working on Infectious Diseases, Epidemiology and Endocrinology. According to data from OpenAlex, Mubarak Alfaresi has authored 39 papers receiving a total of 854 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 12 papers in Epidemiology and 9 papers in Endocrinology. Recurrent topics in Mubarak Alfaresi's work include Antibiotic Resistance in Bacteria (8 papers), Enterobacteriaceae and Cronobacter Research (6 papers) and Pharmaceutical and Antibiotic Environmental Impacts (6 papers). Mubarak Alfaresi is often cited by papers focused on Antibiotic Resistance in Bacteria (8 papers), Enterobacteriaceae and Cronobacter Research (6 papers) and Pharmaceutical and Antibiotic Environmental Impacts (6 papers). Mubarak Alfaresi collaborates with scholars based in United Arab Emirates, Saudi Arabia and Pakistan. Mubarak Alfaresi's co-authors include Hosam M. Zowawi, David L. Paterson, Amina Al‐Jardani, Hanna E. Sidjabat, Timothy R. Walsh, Jameela Al Salman, Ali A. Dashti, Sameera M. Al Johani, Emad Ibrahim and Hanan H. Balkhy and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Clinical Microbiology.

In The Last Decade

Mubarak Alfaresi

38 papers receiving 839 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mubarak Alfaresi United Arab Emirates 15 488 212 205 192 173 39 854
Francis S. Codjoe Ghana 10 533 1.1× 213 1.0× 200 1.0× 93 0.5× 185 1.1× 14 1.1k
Gianluigi Lombardi Italy 13 531 1.1× 228 1.1× 272 1.3× 163 0.8× 123 0.7× 24 773
Chaitra Shankar India 16 709 1.5× 269 1.3× 163 0.8× 162 0.8× 117 0.7× 42 826
Ilhem Boutiba-Ben Boubaker Tunisia 17 630 1.3× 317 1.5× 162 0.8× 217 1.1× 129 0.7× 65 904
Maria Pia Balice Italy 9 591 1.2× 164 0.8× 187 0.9× 302 1.6× 128 0.7× 12 961
Nenad Maćešić Australia 17 577 1.2× 178 0.8× 275 1.3× 209 1.1× 131 0.8× 41 1.0k
Aroonwadee Chanawong Thailand 16 665 1.4× 298 1.4× 124 0.6× 292 1.5× 105 0.6× 49 896
Rebekah M. Martin United States 6 642 1.3× 250 1.2× 222 1.1× 267 1.4× 103 0.6× 13 935
Yamuna Devi Bakthavatchalam India 18 498 1.0× 138 0.7× 147 0.7× 151 0.8× 187 1.1× 61 779
Mohammad Reza Nahaei Iran 21 636 1.3× 240 1.1× 161 0.8× 405 2.1× 196 1.1× 65 1.1k

Countries citing papers authored by Mubarak Alfaresi

Since Specialization
Citations

This map shows the geographic impact of Mubarak Alfaresi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mubarak Alfaresi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mubarak Alfaresi more than expected).

Fields of papers citing papers by Mubarak Alfaresi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mubarak Alfaresi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mubarak Alfaresi. The network helps show where Mubarak Alfaresi may publish in the future.

Co-authorship network of co-authors of Mubarak Alfaresi

This figure shows the co-authorship network connecting the top 25 collaborators of Mubarak Alfaresi. A scholar is included among the top collaborators of Mubarak Alfaresi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mubarak Alfaresi. Mubarak Alfaresi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yong, Shin Jie, Nawal Al Kaabi, Mubarak Alfaresi, et al.. (2025). Serotonergic psychedelics as potential therapeutics for post-COVID-19 syndrome (or Long COVID): A comprehensive review. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 137. 111279–111279.
2.
Rabaan, Ali A., et al.. (2024). Network‐Based Drug Repurposing and Genomic Analysis to Unveil Potential Therapeutics for Monkeypox Virus. Chemistry & Biodiversity. 21(11). e202400895–e202400895. 2 indexed citations
3.
Rabaan, Ali A., Nawal Al Kaabi, Mubarak Alfaresi, et al.. (2024). Antiviral actions of natural compounds against dengue virus RNA dependent RNA polymerase: insights from molecular dynamics and Gibbs free energy landscape. Journal of Biomolecular Structure and Dynamics. 43(16). 9265–9282. 3 indexed citations
4.
Satapathy, Prakasini, Mahalaqua Nazli Khatib, Shilpa Gaidhane, et al.. (2024). Prevalence of human papillomavirus in head and neck cancer patients in India: a systematic review and meta-analysis. BMC Infectious Diseases. 24(1). 516–516. 1 indexed citations
5.
Satapathy, Prakasini, Mahalaqua Nazli Khatib, Shilpa Gaidhane, et al.. (2024). Multi-organ clinical manifestations of Mpox: an umbrella review of systematic reviews. BMC Infectious Diseases. 24(1). 992–992. 4 indexed citations
6.
Imran, Mohd, Mehnaz Kamal, Amal Sabour, et al.. (2024). Non-coding RNAs in meningitis: Key regulators of immune response and inflammation. Pathology - Research and Practice. 263. 155626–155626. 1 indexed citations
7.
Padhi, Bijaya Kumar, Mahalaqua Nazli Khatib, Shilpa Gaidhane, et al.. (2023). Association of cardiovascular disease with severe dengue: A systematic review and meta-analysis. Current Problems in Cardiology. 49(2). 102346–102346. 3 indexed citations
9.
Rabaan, Ali A., Tarek Sulaiman, Shamsah H. Al-Ahmed, et al.. (2023). Potential Strategies to Control the Risk of Antifungal Resistance in Humans: A Comprehensive Review. Antibiotics. 12(3). 608–608. 28 indexed citations
10.
Rabaan, Ali A., Nawal Al Kaabi, Saleh Alshamrani, et al.. (2023). Application of CRISPR-Cas System to Mitigate Superbug Infections. Microorganisms. 11(10). 2404–2404. 8 indexed citations
11.
Rabaan, Ali A., Muhammed A. Bakhrebah, Majed S. Nassar, et al.. (2022). Suspected Adenovirus Causing an Emerging HEPATITIS among Children below 10 Years: A Review. Pathogens. 11(7). 712–712. 11 indexed citations
12.
Rabaan, Ali A., Abbas Al Mutair, Mohammed Aljeldah, et al.. (2022). Genetic Variants and Protective Immunity against SARS-CoV-2. Genes. 13(12). 2355–2355. 3 indexed citations
13.
Rabaan, Ali A., Saad Alhumaid, Abbas Al Mutair, et al.. (2022). Application of Artificial Intelligence in Combating High Antimicrobial Resistance Rates. Antibiotics. 11(6). 784–784. 70 indexed citations
14.
Rabaan, Ali A., Saad Alhumaid, Hawra Albayat, et al.. (2022). Promising Antimycobacterial Activities of Flavonoids against Mycobacterium sp. Drug Targets: A Comprehensive Review. Molecules. 27(16). 5335–5335. 16 indexed citations
15.
Senok, Abiola, Mubarak Alfaresi, Hamda Khansaheb, et al.. (2021). Coinfections in Patients Hospitalized with COVID-19: A Descriptive Study from the United Arab Emirates. Infection and Drug Resistance. Volume 14. 2289–2296. 31 indexed citations
17.
Alfaresi, Mubarak, Garwin Sing, & Abiola Senok. (2018). First Report of blaCTX-M-28 in Enterobacteriaceae Isolates in the United Arab Emirates. SHILAP Revista de lepidopterología. 2018. 1–5. 8 indexed citations
18.
Alfaresi, Mubarak. (2018). Whole Genome Sequencing of Klebsiella pneumoniae Strain Unravels a New Model for the Development of Extensive Drug Resistance in Enterobacteriaceae. The Open Microbiology Journal. 12(1). 195–199. 4 indexed citations
19.
Alfaresi, Mubarak. (2010). Prevalence of hepatitis C virus (HCV) genotypes among positive UAE patients. Molecular Biology Reports. 38(4). 2719–2722. 23 indexed citations
20.
Alfaresi, Mubarak, et al.. (2008). West Nile Virus in the Blood Donors in UAE. Indian Journal of Medical Microbiology. 26(1). 92–93. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026